References
- Whelton P.K. Epidemiology of hypertension. Lancet 1994; 344: 101–106
- Working Group on Primary Prevention of Hypertension. Report of the National High Blood Pressure Education Program Working Group on Primary Prevention of Hypertension. Archives of Internal Medicine 1993; 151: 186–208
- The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Archives of Internal Medicine 1993; 153: 154–183
- Danielson H., Kornerup H., Olsen S., Posberg V. Arterial hypertension in chronic glomerulonephritis. An analysis of 310 cases. Clinical Nephrology 1983; 19: 3353–3358
- Brazy P.C., Fitzwilliam J.F. Progressive renal disease: role of race and antihypertensive medications. Kidney International 1990; 37: 1113–1119
- The National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes. Hypertension 1994; 8: 2–6
- Epstein M. Calcium antagonists and renal protection: current status and future perspectives. Archives of Internal Medicine 1992; 152: 1573–1584
- Bretzel R.G. Protecting the residual renal function: which drugs of choice?. American Journal of Hypertension 1997; 10: 159s–166s
- Takabatake T., Ohta H., Sasaki T., Satoh S., Ohta K., Ise T., Kobayashi K. Renal effects of manidipine hydrochloride. European Journal of Clinical Pharmacology 1993; 45: 321–325
- Gault M.H., Longerich L.L., Harnett J.D., Wesolowsky C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992; 62: 249–256
- Neaton J.D., Grimm R.H., Jr., Prineas R.J. Treatment of mild hypertension study. JAMA 1993; 270: 713–724
- Elliot W.J. Drug therapy and drops out in a tertiary hypertension clinic. American Journal of Hypertension 1994; 25: 1356
- Fogari R., Zoppi A., Corradi L., Preti P., Malalamani G.D., Mugellini A. Effect of different dyhydropyridine calcium antagonist on plasma norepinephrine in essential hypertension. J. Hypertens. 2000; 18: 1871–1875
- Van Zwieten P.A., Pfaffendorf M., Mancia G. Attempts to improve the selectivity of calcium antagonistic drugs. Blood Pressure 1996; 5(suppl 5)7–9
- Epstain M. Calcium antagonist and the kidney. American Journal of Hypertension 1993; 6: 251s–259s
- Sabbatini M., Leonardi A., Testa R., Vitaioli L., Amenta F. Effects of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000; 35: 775–779
- Keane W.J., Raij L. Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Laboratory Investigation 1985; 52: 599–604